Literature DB >> 20309933

p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.

Takahiko Kobayashi1, Junich Ishida, Manabu Musashi, Shuichi Ota, Takeshi Yoshida, Yuichi Shimizu, Makoto Chuma, Hiroshi Kawakami, Masahiro Asaka, Junji Tanaka, Masahiro Imamura, Masanobu Kobayashi, Hiroshi Itoh, Hironori Edamatsu, Leslie C Sutherland, Rainer K Brachmann.   

Abstract

RBM5 (RNA-binding motif protein 5) is a nuclear RNA binding protein containing 2 RNA recognition motifs. The RBM5 gene is located at the tumor suppressor locus 3p21.3. Deletion of this locus is the most frequent genetic alteration in lung cancer, but is also found in other human cancers. RBM5 is known to induce apoptosis and cell cycle arrest but the molecular mechanisms of RBM5 function are poorly understood. Here, we show that RBM5 is important for the activity of the tumor suppressor protein p53. Overexpression of RBM5 enhanced p53-mediated inhibition of cell growth and colony formation. Expression of RBM5 augmented p53 transcriptional activity in reporter gene assays and resulted in increased mRNA and protein levels for endogenous p53 target genes. In contrast, shRNA-mediated knockdown of endogenous RBM5 led to decreased p53 transcriptional activity and reduced levels of mRNA and protein for endogenous p53 target genes. RBM5 affected protein, but not mRNA, levels of endogenous p53 after DNA damage suggest that RBM5 contributes to p53 activity through post-transcriptional mechanisms. Our results show that RBM5 contributes to p53 transcriptional activity after DNA damage and that growth suppression and apoptosis mediated by RBM5 are linked to activity of the tumor suppressor protein p53.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309933     DOI: 10.1002/ijc.25345

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

2.  Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Authors:  Jose Russo; Julia Santucci-Pereira; Ricardo López de Cicco; Fathima Sheriff; Patricia A Russo; Suraj Peri; Michael Slifker; Eric Ross; Maria Luiza S Mello; Benedicto C Vidal; Ilana Belitskaya-Lévy; Alan Arslan; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Ahman; Yelena Afanasyeva; Goran Hallmans; Paolo Toniolo; Irma H Russo
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

3.  RNA Binding Motif 5 Gene Deletion Modulates Cell Signaling in a Sex-Dependent Manner but Not Hippocampal Cell Death.

Authors:  Jeffrey Farooq; Kara Snyder; Keri Janesko-Feldman; Kiersten Gorse; Vincent A Vagni; Patrick M Kochanek; Travis C Jackson
Journal:  J Neurotrauma       Date:  2022-03-01       Impact factor: 5.269

Review 4.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

5.  BrainPhys® increases neurofilament levels in CNS cultures, and facilitates investigation of axonal damage after a mechanical stretch-injury in vitro.

Authors:  Travis C Jackson; Shawn E Kotermanski; Edwin K Jackson; Patrick M Kochanek
Journal:  Exp Neurol       Date:  2017-12-01       Impact factor: 5.330

6.  Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.

Authors:  Zhenzhong Su; Jinzhi Yin; Lijing Zhao; Ranwei Li; Hong Liang; Jie Zhang; Ke Wang
Journal:  World J Surg Oncol       Date:  2014-12-02       Impact factor: 2.754

Review 7.  Molecular pathways involved in pregnancy-induced prevention against breast cancer.

Authors:  Maria Barton; Julia Santucci-Pereira; Jose Russo
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-10       Impact factor: 5.555

8.  Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features.

Authors:  Jie Peng; Ali Kord Valeshabad; Qingfu Li; Yuan Wang
Journal:  Oncol Lett       Date:  2012-12-17       Impact factor: 2.967

9.  The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.

Authors:  Chen Shao; Lijing Zhao; Ke Wang; Wei Xu; Jie Zhang; Baoxue Yang
Journal:  World J Surg Oncol       Date:  2012-08-06       Impact factor: 2.754

10.  3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis.

Authors:  Lijing Zhao; Ranwei Li; Chen Shao; Ping Li; Jian Liu; Ke Wang
Journal:  World J Surg Oncol       Date:  2012-11-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.